BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
+4.86%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$721M
AUM Growth
+$721M
(+0.55%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
29.13%
Holding
154
New
13
Increased
38
Reduced
45
Closed
14
Top Buys
| 1 |
Illumina
ILMN
|
$5.94M |
| 2 |
ENDP
Endo International plc
ENDP
|
$5.73M |
| 3 |
Cencora
COR
|
$5.32M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$5.21M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.21M |
Top Sells
| 1 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$18.9M |
| 2 |
Baxter International
BAX
|
$9.56M |
| 3 |
Centene
CNC
|
$9.48M |
| 4 |
LCI
Lannett Company, Inc.
LCI
|
$6.61M |
| 5 |
Molina Healthcare
MOH
|
$6.39M |
Sector Composition
| 1 | Healthcare | 90.06% |
| 2 | Financials | 0.8% |
| 3 | Industrials | 0.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $29.4M | 4.08% | 72,760 +2,030 | +3% | +$820K |
|
2
Gilead Sciences
GILD
$140B
| $27.5M | 3.82% | 234,900 +1,090 | +0.5% | +$128K |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $26.5M | 3.67% | 228,680 +2,890 | +1% | +$334K |
|
4
Abbott
ABT
$231B
| $22.7M | 3.15% | 463,000 -44,000 | -9% | -$2.16M |
|
5
Medtronic
MDT
$119B
| $20.7M | 2.88% | 280,000 -60,000 | -18% | -$4.45M |
|
|
6
Regeneron Pharmaceuticals
REGN
$61.5B
| $19.8M | 2.75% | 38,800 +10,205 | +36% | +$5.21M |
|
|
7
Illumina
ILMN
$15.8B
| $18.1M | 2.51% | 82,739 +27,180 | +49% | +$5.94M |
|
8
Viatris
VTRS
$12.3B
| $15.3M | 2.12% | 225,000 +60,000 | +36% | +$4.07M |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $15M | 2.08% | 49,420 +690 | +1% | +$209K |
|
|
ENDP
10
DELISTED
Endo International plc
ENDP
| $15M | 2.08% | 188,000 +72,000 | +62% | +$5.73M |
|
11
Amgen
AMGN
$155B
| $14.9M | 2.06% | 96,866 -13,000 | -12% | -$2M |
|
|
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
| $14.2M | 1.97% | 160,000 +20,000 | +14% | +$1.78M |
|
13
UnitedHealth
UNH
$281B
| $14M | 1.95% | 115,000 | – | – |
|
14
Stryker
SYK
$150B
| $13.4M | 1.87% | 140,700 -5,000 | -3% | -$478K |
|
15
Becton Dickinson
BDX
$55.3B
| $12.8M | 1.78% | 90,630 +32,022 | +55% | +$4.54M |
|
|
STJ
16
DELISTED
St Jude Medical
STJ
| $11M | 1.52% | 150,000 -1,000 | -0.7% | -$73.1K |
|
17
Vertex Pharmaceuticals
VRTX
$100B
| $10.9M | 1.52% | 88,500 -5,000 | -5% | -$617K |
|
|
CYTO
18
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $10.7M | 1.49% | 2,169,625 | – | – |
|
|
KITE
19
DELISTED
Kite Pharma, Inc.
KITE
| $10.7M | 1.48% | 175,000 +7,000 | +4% | +$427K |
|
20
Zimmer Biomet
ZBH
$21B
| $10.4M | 1.45% | 95,500 | – | – |
|
21
Cardinal Health
CAH
$35.5B
| $10.3M | 1.43% | 123,000 +33,000 | +37% | +$2.76M |
|
22
Teva Pharmaceuticals
TEVA
$21.1B
| $9.87M | 1.37% | 166,950 +26,950 | +19% | +$1.59M |
|
23
Jazz Pharmaceuticals
JAZZ
$7.75B
| $9.86M | 1.37% | 56,000 -2,500 | -4% | -$440K |
|
|
ALXN
24
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.35M | 1.3% | 51,746 -21,000 | -29% | -$3.8M |
|
25
Community Health Systems
CYH
$387M
| $9.34M | 1.3% | 148,250 +78,250 | +112% | +$4.93M |
|